These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34219144)

  • 21. Low-dose colchicine for coronary artery disease.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):54-55. PubMed ID: 33830969
    [No Abstract]   [Full Text] [Related]  

  • 22. Colchicine for Secondary Cardiovascular Prevention: A Systematic Review.
    Webb CA; Barry AR
    Pharmacotherapy; 2020 Jun; 40(6):575-583. PubMed ID: 32259308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distinct role of secondary prevention in patients with prior coronary interventions.
    Colmenarez H; Escaned J
    EuroIntervention; 2009 May; 5 Suppl D():D131-8. PubMed ID: 19736062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and secondary prevention of coronary artery disease.
    Kahali D; Dey T; Mondal S
    J Indian Med Assoc; 2009 Oct; 107(10):675-8. PubMed ID: 20469740
    [No Abstract]   [Full Text] [Related]  

  • 26. Time to commence or time out for colchicine in secondary prevention of cardiovascular disease?
    Pradhan AD
    Eur Heart J; 2021 Jul; 42(28):2776-2779. PubMed ID: 33824963
    [No Abstract]   [Full Text] [Related]  

  • 27. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
    Opstal TSJ; van Broekhoven A; Fiolet ATL; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Budgeon CA; Bartels L; de Nooijer R; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH
    Circulation; 2022 Feb; 145(8):626-628. PubMed ID: 35188792
    [No Abstract]   [Full Text] [Related]  

  • 29. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary artery disease prevention: as easy as 1, 2, 3?
    Lucan SC
    Am Fam Physician; 2010 Nov; 82(10):1167. PubMed ID: 21121526
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and Efficacy of Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Ullah W; Gowda SN; Fischman D
    Cardiovasc Revasc Med; 2021 Feb; 23():1-6. PubMed ID: 32553442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
    Opstal TSJ; Fiolet ATL; van Broekhoven A; Mosterd A; Eikelboom JW; Nidorf SM; Thompson PL; Duyvendak M; van Eck JWM; van Beek EA; den Hartog F; Budgeon CA; Bax WA; Tijssen JGP; El Messaoudi S; Cornel JH;
    J Am Coll Cardiol; 2021 Aug; 78(9):859-866. PubMed ID: 34446156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atorvastatin for secondary prevention in patients with coronary artery disease].
    Zateĭshchikova AA; Sidorenko BA
    Kardiologiia; 2011; 51(12):63-9. PubMed ID: 22304319
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
    Cohn JN
    Ann Intern Med; 2021 Jan; 174(1):JC8. PubMed ID: 33395340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applying the evidence in coronary disease secondary prevention: a call to action.
    Newby LK
    J Am Coll Cardiol; 2014 Feb; 63(6):547-8. PubMed ID: 24184241
    [No Abstract]   [Full Text] [Related]  

  • 36. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
    Fiolet ATL; Silvis MJM; Opstal TSJ; Bax WA; van der Horst FAL; Mosterd A; de Kleijn D; Cornel JH
    PLoS One; 2020; 15(8):e0237665. PubMed ID: 32866166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention.
    Kilic ID; Fabris E; Kedhi E; Ghilencea LN; Caiazzo G; Sherif SA; Di Mario C
    Curr Atheroscler Rep; 2020 Oct; 22(12):76. PubMed ID: 33025069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chinese experts consensus on cardiac rehabilitation/secondary prevention for coronary artery disease].
    ; ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Apr; 41(4):267-75. PubMed ID: 23906394
    [No Abstract]   [Full Text] [Related]  

  • 39. To maintain a proper follow-up of the patients with coronary artery disease is as nearly important as medications.
    Demirkol S; Cakar M; Balta S; Unlu M; Ay SA; Karaman M
    Int J Cardiol; 2013 Sep; 167(5):2372. PubMed ID: 23201080
    [No Abstract]   [Full Text] [Related]  

  • 40. Colchicine prevents stroke in patients with coronary artery disease - a trial sequential analysis.
    Chan JSK
    Eur J Neurol; 2020 Jul; 27(7):e28. PubMed ID: 32202673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.